Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Marlene, Seegräber"'
Autor:
Heinzerling, Dirk Tomsitz, Theresa Ruf, Markus Heppt, Ramon Staeger, Egle Ramelyte, Reinhard Dummer, Marlene Garzarolli, Friedegund Meier, Eileen Meier, Heike Richly, Tanja Gromke, Jens T. Siveke, Cindy Franklin, Kai-Christian Klespe, Cornelia Mauch, Teresa Kilian, Marlene Seegräber, Bastian Schilling, Lars E. French, Carola Berking, Lucie
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3430
Background: Tebentafusp has recently been approved for the treatment of metastatic uveal melanoma (mUM) after proving to have survival benefits in a first-line setting. Patients and Methods: This retrospective, multicenter study analyzed the outcomes
Publikováno v:
Der Hautarzt. 71:2-5
Publikováno v:
Der Hautarzt. 71:57-59
Autor:
Kinan Hayani, Michael J. Flaig, Marlene Seegräber, Suzan Nasifoglu, Max Schlaak, Laura Engels, Diana Lill, Elke Sattler, Ortrud K. Steinlein, Jerome Srour
Publikováno v:
Der Hautarzt. 71:44-46
Autor:
Nora Aszodi, Andreas Wollenberg, Stephan R. Thurau, Marlene Seegräber, Marjolein S. de Bruin-Weller
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 17:488-492
Der monoklonale Antikorper Dupilumab (Dupixent® ) ist seit September 2017 in der EU als neue systemische Therapie bei mittelschwerem bis schwerem atopischem Ekzem zugelassen. Eine Unterdruckung der IL-4- und IL-13-Signalwege durch die Anwendung von
Autor:
Jerome, Srour, Marlene, Seegräber, Suzan, Nasifoglu, Max, Schlaak, Andreas, Wollenberg, Michael J, Flaig, Elke, Sattler
Publikováno v:
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 71(Suppl 1)
Autor:
Suzan, Nasifoglu, Jerome, Srour, Diana, Lill, Marlene, Seegräber, Elke, Sattler, Max, Schlaak
Publikováno v:
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 71(Suppl 1)
Autor:
Benjamin Kendziora, Marlene Seegräber, Laurie Eicher, Sonja Senner, Surina Frey, Andreas Wollenberg
Publikováno v:
Expert review of clinical immunology. 16(7)
Dupilumab is a treatment option newly licensed for adolescents with moderate to severe atopic dermatitis (AD). It reduces type 2 inflammation by blocking the shared receptor subunit for IL-4/-13. Dupilumab affects three disease mechanisms in atopic d
Autor:
Natalija Novak, Ulf Darsow, Marlene Seegräber, Åke Svensson, Dagmar Simon, Matthias Augustin, Margitta Worm, Andreas Wollenberg, Thomas Werfel
Publikováno v:
Seegräber, Marlene; Worm, Margitta; Werfel, Thomas; Svensson, Ake; Novak, Natalija; Simon, Dagmar; Darsow, Ulf; Augustin, Matthias; Wollenberg, Andreas (2020). Recurrent Eczema Herpeticum-A Retrospective European Multicenter Study Evaluating the Clinical Characteristics of Eczema Herpeticum Cases in Atopic Dermatitis Patients. Journal of the European Academy of Dermatology and Venereology : JEADV, 34(5), pp. 1074-1079. Wiley 10.1111/jdv.16090
Background Eczema herpeticum (EH ) is a disseminated viral infection of eczematous skin disease with the herpes simplex virus. Knowledge on clinical characteristics, risk factors and recurrent disease is limited. Our aim was to better define clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a515b8391d60af1c4cd1afee4bf5601c
Publikováno v:
Clinical Reviews in Allergy & Immunology. 56:19-31
A wide variety of foods may cause or aggravate skin diseases such as contact dermatitis, contact urticaria, or atopic dermatitis (AD), both in occupational and private settings. The mechanism of action underlying allergic disease to food, food additi